Eiko Lifesciences Ltd — Board Meeting, 26-05-2026: Board Meeting

Eiko Lifesciences' board approved its financial results for the quarter and year ended March 31, 2026. Consolidated revenue hit ₹18.34 Cr (Q4) and ₹52.71 Cr (FY). Net profit reached ₹1.50 Cr (Q4) and ₹5.32 Cr (FY). M/s NP Rajput & Co. was appointed as Internal Auditor for FY27.